Dyno Therapeutics
Daniela Pignatta has a vast experience in genomics and molecular biology, having worked in various prestigious research institutes and companies. With a background in investigating gene imprinting, small RNAs in plant immune receptors, and non-additive gene expression, Daniela has held significant roles such as Director, Associate Director of Genomics, and Research Scientist. Currently, Daniela serves as the Director and Team Lead at Dyno Therapeutics.
This person is not in any offices
Dyno Therapeutics
4 followers
Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.